Close

Gabelli Downgrades Assertio Therapeutics (ASRT) to Hold

December 17, 2020 8:28 AM EST Send to a Friend
Gabelli analyst Kevin Kendra downgraded Assertio Therapeutics (NASDAQ: ASRT) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login